Protein kinases in neurodegenerative diseases: current understandings and implications for drug discovery
Abstract Neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s, Huntington’s disease, and Amyotrophic Lateral Sclerosis) are major health threats for the aging population and their prevalences continue to rise with the increasing of life expectancy. Although progress has been made, there is sti...
Saved in:
| Main Authors: | Xiaolei Wu, Zhangzhong Yang, Jinjun Zou, Huile Gao, Zhenhua Shao, Chuanzhou Li, Peng Lei |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-05-01
|
| Series: | Signal Transduction and Targeted Therapy |
| Online Access: | https://doi.org/10.1038/s41392-025-02179-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tracking protein kinase targeting advances: integrating QSAR into machine learning for kinase-targeted drug discovery
by: Rand Shahin, et al.
Published: (2025-12-01) -
A Survey on Computational Methods in Drug Discovery for Neurodegenerative Diseases
by: Caterina Vicidomini, et al.
Published: (2024-10-01) -
Tyrosine kinase as therapeutic target of neurodegenerative disorders
by: Dipanjan Karati, et al.
Published: (2025-03-01) -
Advancements in Protein Kinase Inhibitors: From Discovery to Clinical Applications
by: Salem Baldi, et al.
Published: (2025-01-01) -
Pharmacophore Modeling of Janus Kinase Inhibitors: Tools for Drug Discovery and Exposition Prediction
by: Florian Fischer, et al.
Published: (2025-05-01)